clenbuterol has been researched along with Alzheimer Disease in 2 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Excerpt | Relevance | Reference |
|---|---|---|
| "As neurodegenerative disorder, Alzheimer's Disease (AD) is postulated to share a common molecular mechanism with glaucoma." | 1.72 | Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance. ( Hohberger, B; Lämmer, R; Mardin, C; Müller, J; Prüss, H; Wallukat, G, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hohberger, B | 1 |
| Prüss, H | 1 |
| Mardin, C | 1 |
| Lämmer, R | 1 |
| Müller, J | 1 |
| Wallukat, G | 1 |
| Yu, NN | 1 |
| Wang, XX | 1 |
| Yu, JT | 1 |
| Wang, ND | 1 |
| Lu, RC | 1 |
| Miao, D | 1 |
| Tian, Y | 1 |
| Tan, L | 1 |
2 other studies available for clenbuterol and Alzheimer Disease
| Article | Year |
|---|---|
Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance.
Topics: Adrenergic Agents; Alzheimer Disease; Amyloid beta-Peptides; Animals; Autoantibodies; Clenbuterol; G | 2022 |
Blocking beta2-adrenergic receptor attenuates acute stress-induced amyloid beta peptides production.
Topics: Acute Disease; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Ant | 2010 |